OVERVIEW: *Free, half-day virtual event. *Hear from inventors from the National Cancer Institute and the Frederick National Laboratory about technologies primed for commercialization and/or collaboration; great opportunity for biotech stakeholders [….]
Frederick, Maryland has its fair share of impressive features: it’s just 40 miles from both Washington, D.C., and Baltimore, it’s home to more than 10 craft breweries, and it’s also the site of over 80 biotech businesses.
This year, more than ever before, we’ve seen just how important it is for us all to stay connected and work together to build a stronger biotech ecosystem. In the face of great adversity, the biotech community has risen to the challenge and formed new collaborations and partnerships to innovate and rapidly develop new medicines and tools to help us beat this pandemic.
Reserve the afternoon of September 9th on your calendar for the 2020 Technology Showcase. The 4th annual event will highlight technologies being developed at the NCI and Frederick National Laboratory for Cancer [….]
Reserve the afternoon of June 17th on your calendar for the 2020 Technology Showcase. The 4th annual event will highlight technologies being developed at the NCI and Frederick National Laboratory [….]
Advancements In Gene Editing and CRISPR Emerging From Frederick, Maryland’s Vibrant BioHub A strong crowd of BioHealth Capital Region (BHCR) lab researchers, genomic scientists, and other life science industry members [….]
Frederick National Labs Attract Entrepreneurs and Collaborators Seeking Leading-Edge Biomedical Technologies
Frederick National Labs Attract Entrepreneurs and Collaborators Seeking Leading-Edge Biomedical Technologies Tech Transfer Event Attracts Leading Researchers, Postdocs and Investors from Across the BioHealth Capital Region and Beyond June 18, [….]
Three Examples of Commercializing Blockbuster Technologies from NCI
The 2nd Annual Tech Showcase Reflects New Culture at NCI & FNLCR When you hear the term “government research” do the words “entrepreneur”, “start-up”, “commercially relevant” or “industry partner” come to [….]